Clinical trial · Interventional
OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.
NCT04074642CI-TRIAL-00106368FIRSTcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and OCT.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pituitary Adenoma | Pituitary Neuroendocrine Tumor | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Neurosurgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Non compressive adenoma
- description
- Optical Coherence Tomography Angiography without surgery
- type
- EXPERIMENTAL
- label
- Compressive adenoma
- description
- Optical Coherence Tomography Angiography before and after neurosurgery
- interventionNames
- Procedure: Neurosurgery
Primary outcomes (2)
- measure
- change of middle deviation
- timeFrame
- before surgery (= inclusion), 4 months after surgery and 10 months after surgery
- description
- visual field evolution assessed by Middle deviation
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * pituitary compressive adenoma (for experimental group) * pituitary non compressive adenoma Exclusion Criteria: * retinian disease * amblyopia * parkinson disease * pregnant woman
References
Publications (1)
- RESULTToumi E, Almairac F, Mondot L, Themelin A, Decoux-Poullot AG, Paquis P, Chevalier N, Baillif S, Nahon-Esteve S, Martel A. Benefit of Optical Coherence Tomography-Angiography in Patients Undergoing Transsphenoidal Pituitary Adenoma Surgery: A Prospective Controlled Study. Diagnostics (Basel). 2024 Aug 12;14(16):1747. doi: 10.3390/diagnostics14161747. PMID 39202235